| Year |
Citation |
Score |
| 2024 |
Garg M, Puckett J, Kamal-Bahl S, Raut M, Ryland KE, Doshi JA, Huntington SF. Real-World Survival, Healthcare Resource Utilization, and Costs Among U.S. Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated With R-GemOx in the Relapsed/Refractory Setting. Clinical Lymphoma, Myeloma & Leukemia. PMID 38433043 DOI: 10.1016/j.clml.2024.01.010 |
0.574 |
|
| 2024 |
Huntington SF, de Nigris E, Puckett JT, Kamal-Bahl S, Farooqui M, Ryland K, Sarpong EM, Leng S, Yang X, Doshi JA. Real-world analysis of adverse event rates after initiation of ibrutinib among Medicare beneficiaries with chronic lymphocytic leukemia. Cancer Medicine. 13: e6953. PMID 38348963 DOI: 10.1002/cam4.6953 |
0.494 |
|
| 2023 |
Garg M, Puckett J, Kamal-Bahl S, Raut M, Ryland KE, Doshi JA, Huntington SF. Real-world treatment patterns, survival, health resource use and costs among Medicare beneficiaries with diffuse large B-cell lymphoma. Future Oncology (London, England). PMID 38050764 DOI: 10.2217/fon-2023-0191 |
0.668 |
|
| 2023 |
Huntington SF, de Nigris E, Puckett J, Kamal-Bahl S, Farooqui M, Ryland K, Sarpong E, Leng S, Yang X, Doshi JA. Ibrutinib discontinuation and associated factors in a real-world national sample of elderly Medicare beneficiaries with chronic lymphocytic leukemia. Leukemia & Lymphoma. 1-10. PMID 37870435 DOI: 10.1080/10428194.2023.2256911 |
0.554 |
|
| 2023 |
Huntington SF, Manzoor BS, Puckett JT, Kamal-Bahl S, Alhasani H, Ravelo A, Jawaid D, Doshi JA. Real-world adherence and discontinuation among Medicare beneficiaries initiating venetoclax vs. BTKis in relapsed/refractory chronic lymphocytic leukemia. Leukemia & Lymphoma. 1-8. PMID 37732602 DOI: 10.1080/10428194.2023.2255326 |
0.545 |
|
| 2023 |
Squires P, Puckett J, Ryland KE, Kamal-Bahl S, Raut M, Doshi JA, Huntington SF. Assessing unmet need among elderly Medicare Beneficiaries with Mantle cell lymphoma: an analysis of treatment patterns, survival, healthcare resource utilization, and costs. Leukemia & Lymphoma. 64: 1752-1770. PMID 37497877 DOI: 10.1080/10428194.2023.2234525 |
0.666 |
|
| 2022 |
Dubberke ER, Puckett JT, Obi EN, Kamal-Bahl S, Desai K, Stuart B, Doshi JA. Impact of Updated Clinical Practice Guidelines on Outpatient Treatment for Infection and Associated Clinical Outcomes. Open Forum Infectious Diseases. 9: ofac435. PMID 36267250 DOI: 10.1093/ofid/ofac435 |
0.594 |
|
| 2022 |
Stuart B, Loh FE, Kamal-Bahl S, Vietri J, Bakken D, Puckett J, Doshi JA. Financial incentives tied to Medicare star ratings: impact on influenza vaccination uptake in Medicare beneficiaries. The American Journal of Managed Care. 28: 273-280. PMID 35738223 DOI: 10.37765/ajmc.2022.89154 |
0.56 |
|
| 2008 |
Stuart B, Lloyd J, Zhao L, Kamal-Bahl S. Obesity, disease burden, and prescription spending by community-dwelling Medicare beneficiaries. Current Medical Research and Opinion. 24: 2377-87. PMID 18616864 DOI: 10.1185/03007990802262275 |
0.456 |
|
| 2006 |
Kamal-Bahl SJ, Stuart BC, Beers MH. Propoxyphene use and risk for hip fractures in older adults. The American Journal of Geriatric Pharmacotherapy. 4: 219-26. PMID 17062322 DOI: 10.1016/J.Amjopharm.2006.09.005 |
0.551 |
|
| 2005 |
Kamal-Bahl S, Stuart BC, Beers MH. National trends in and predictors of propoxyphene use in community-dwelling older adults. The American Journal of Geriatric Pharmacotherapy. 3: 186-95. PMID 16257821 DOI: 10.1016/S1543-5946(05)80025-X |
0.539 |
|
| 2005 |
Kamal-Bahl S, Briesacher B. How do incentive-based formularies influence drug selection and spending for hypertension? Health Affairs (Project Hope). 23: 227-36. PMID 15002647 DOI: 10.1377/Hlthaff.23.1.227 |
0.306 |
|
| 2004 |
Morton AH, Goldstein DJ, Kamal-Bahl SJ, Doshi JA, Stuart BC, Briesacher BA. Inappropriately defining "inappropriate medication for the elderly" [1] (multiple letters) Journal of the American Geriatrics Society. 52: 1580-1582. PMID 15341569 |
0.585 |
|
| 2004 |
Briesacher B, Kamal-Bahl S, Hochberg M, Orwig D, Kahler KH. Three-tiered-copayment drug coverage and use of nonsteroidal anti-inflammatory drugs. Archives of Internal Medicine. 164: 1679-84. PMID 15302639 DOI: 10.1001/Archinte.164.15.1679 |
0.348 |
|
| 2003 |
Stuart B, Kamal-Bahl S, Briesacher B, Lee E, Doshi J, Zuckerman IH, Verovsky I, Beers MH, Erwin G, Friedley N. Trends in the prescription of inappropriate drugs for the elderly between 1995 and 1999. The American Journal of Geriatric Pharmacotherapy. 1: 61-74. PMID 15555468 DOI: 10.1016/S1543-5946(03)90002-X |
0.639 |
|
| 2003 |
Kamal-Bahl SJ, Doshi JA, Stuart BC, Briesacher BA. Propoxyphene use by community-dwelling and institutionalized elderly Medicare beneficiaries. Journal of the American Geriatrics Society. 51: 1099-104. PMID 12890072 DOI: 10.1046/J.1532-5415.2003.51358.X |
0.602 |
|
| 2002 |
Kamal-Bahl S, Doshi J, Campbell J. Economic analyses of respiratory syncytial virus immunoprophylaxis in high-risk infants: a systematic review. Archives of Pediatrics & Adolescent Medicine. 156: 1034-41. PMID 12361451 DOI: 10.1001/Archpedi.156.10.1034 |
0.483 |
|
| Show low-probability matches. |